media reports
U-NEURON Targets Multi-Billion ED Blue Ocean Market, Launching Dual-Engine Growth in Healthcare and Aesthetics
U-NEURON Chairman Dr. Frank Chien Projects Turnaround to Profitability Next Year
Pioneering Patented Amniotic Fluid Stem Cell Technology! Targeting a Multi-Billion-Dollar Market, U-NEURON Chairman States: “Anyone Dissatisfied with Viagra Is Our Customer”
U-NEURON (6973) leverages its world-leading patented amniotic fluid stem cell technology to address the multi-billion-dollar blue ocean market of male erectile dysfunction (ED).
Yonglirong’s revenue/March was 10.56 million yuan, an annual increase of 24.2%, a new high of 26.7 million yuan in the first quarter
Yonglirong (6973) announced on the 7th that its revenue in March 2026 was 10.56 million yuan, an annual increase of 24.25% and a monthly increase of 30.43%; the cumulative first quarter of 2026...
Dual engine assist! Yonglirong’s first-quarter revenue reached 26.7 million yuan, a new high for the same period
Yonglirong (6973)'s consolidated revenue in March reached 10.56 million yuan, a monthly increase of 30.43% and an annual increase of 24.25%; the cumulative first quarter consolidated revenue reached...